Purpose: To compare the occurrence of malignancy in patients with severe ocular inflammatory disease treated with systemic corticosteroids alone or with systemic im-munosuppressive drugs with or without systemic corticosteroids. Methods: The clinical records of 543 patients with ocular inflammatory disease treated with systemic corticosteroids andfor immunosuppressive chemotherapy were reviewed in a retrospective cohort study. Characteristics of patients treated with cor-ticosteroids alone were compared with characteristics of patients treated with immu-nosuppressive agents with or without preceding corticosteroid treatment. The rates of malignancy after initiation of drug therapy were compared using an exact test for inci-dence rate data. ...
Background: Immune-related adverse events (irAEs) are inflammatory side effects, which can occur dur...
The long-term risk of malignancies in patients treated with immunosuppressive drugs is a concern amo...
Patients with autoimmune rheumatic diseases including rheumatoid arthritis (RA), systemic lupus eryt...
Purpose: To estimate the frequency of first-time ocular events in patients treated with immune check...
AbstractOcular inflammation is a significant cause of ocular morbidity and visual impairment. Topica...
Purpose: To prospectively compare 2 immunosupressive regimens in patients with active Vogt-Koyanagi-...
PURPOSE: To compare the effect of early systemic immunomodulatory treatment and to identify prognost...
Abstract PURPOSE: This study aimed to assess the effectiveness of a steroid-sparing immunosuppressi...
Purpose: New tumor therapies like immune checkpoint inhibitors and small molecule inhibitors of MEK ...
Inhibitors of tumor necrosing factor alpha (TNF-a) have proven to be highly effective in the treatme...
Background Immune checkpoint inhibitors (ICIs) are important new therapeutic options for the treatme...
Contains fulltext : 138289.pdf (publisher's version ) (Closed access)BACKGROUND: A...
Objectives: No large assessment of the general cancer occurrence in eosinophilic granulomatosis with...
Background: The association between multiple sclerosis (MS) and cancer has long been investigated wi...
Purpose: To evaluate the safety and efficacy of standard DMARD compared with biologic immuno...
Background: Immune-related adverse events (irAEs) are inflammatory side effects, which can occur dur...
The long-term risk of malignancies in patients treated with immunosuppressive drugs is a concern amo...
Patients with autoimmune rheumatic diseases including rheumatoid arthritis (RA), systemic lupus eryt...
Purpose: To estimate the frequency of first-time ocular events in patients treated with immune check...
AbstractOcular inflammation is a significant cause of ocular morbidity and visual impairment. Topica...
Purpose: To prospectively compare 2 immunosupressive regimens in patients with active Vogt-Koyanagi-...
PURPOSE: To compare the effect of early systemic immunomodulatory treatment and to identify prognost...
Abstract PURPOSE: This study aimed to assess the effectiveness of a steroid-sparing immunosuppressi...
Purpose: New tumor therapies like immune checkpoint inhibitors and small molecule inhibitors of MEK ...
Inhibitors of tumor necrosing factor alpha (TNF-a) have proven to be highly effective in the treatme...
Background Immune checkpoint inhibitors (ICIs) are important new therapeutic options for the treatme...
Contains fulltext : 138289.pdf (publisher's version ) (Closed access)BACKGROUND: A...
Objectives: No large assessment of the general cancer occurrence in eosinophilic granulomatosis with...
Background: The association between multiple sclerosis (MS) and cancer has long been investigated wi...
Purpose: To evaluate the safety and efficacy of standard DMARD compared with biologic immuno...
Background: Immune-related adverse events (irAEs) are inflammatory side effects, which can occur dur...
The long-term risk of malignancies in patients treated with immunosuppressive drugs is a concern amo...
Patients with autoimmune rheumatic diseases including rheumatoid arthritis (RA), systemic lupus eryt...